In Contact With DGPharMed – What Investors Want to Know from Clinically Researching Biotech Startups

📅 Date: 09.12.2024
🕕 Time: 6 pm (followed by drinks and snacks! 🍿🥤)
🏢 Format: Hybrid (personal attendance is strongly recommended. A certificate can be issued for on-site participation).

Take part in an exclusive workshop on the topic: What Investors Want to Know from Clinically Researching Biotech Startups

About DGPharMed:
The DGPharMed e.V. is a scientific-medical professional association for doctors, scientists, university graduates and other specialists in pharmaceutical medicine. Its members work in the pharmaceutical industry and medical technology as well as in clinics, medical practices, CROs and other scientific organisations or institutions.

As a multidisciplinary speciality, pharmaceutical medicine encompasses the entire field of discovery, research and development of medicinal products, their regulatory approval and benefit assessment as well as medical care in practical application.

Workshop description:
ICON is a global provider of consulting, and outsourced development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health organisations. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost and increasing quality. Peter Schüler, MD, Neurologist, is Sr VP Drug Development Solutions for the Neurosciences and Immunology at ICON and President of the German Society for Pharmaceutical Medicine (DGPharMed). He will detail the fundaments of a successful pitch to investors.

Thereafter, on-site participants can develop their own proposal and discuss it in the team or individually.

Zoom access data:
Topic: BioContact - In Contact With DGPharMed
Time: 09. December 2024, 6 pm (Amsterdam, Berlin, Rome, Stockholm, Vienna)

Meeting-ID: 83956548742
Password: ICW_DGPh

See you on 09 December!

Der Beitrag ICW DGPharMed erschien zuerst auf BioContact e.V. (English).